Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability.

Biotechnology & genetic engineering reviews - 1 Dec 2024

Yerrakula Goutham, Abraham Shyno, John Shiji, Zeharvi Mehrukh, George Samuel Gideon, Senthil V, Maiz Fathi, Rahman Md Habibur

Abstract excerpt

The number of studies and reviews conducted for the Carboxylesterase gene is limited in comparison with other enzymes. Carboxylesterase (CES) gene or human carboxylesterases (hCES) is a multigene protein belonging to the α/β-hydrolase family. Over the last decade, two major carboxylesterases (CES1 and CES2), located at 16q13-q22.1 on human chromosome 16 have been extensively studied as important mediators in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Biological Availability

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carboxylesterase

Share to Carboxylic Ester Hydrolases

Share to Polymorphism, Single Nucleotide

Share to Substrate Specificity

Source

Identifiers

PMID: 35946821
DOI: 10.1080/02648725.2022.2108997

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability.PMID 35946821Read ↗

Clinical implications of genetic variation in carboxylesterase drug metabolism.Semantic proximity Read ↗

A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms.Semantic proximity Read ↗

The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.Semantic proximity Read ↗

Carboxylesterase 1 genetic variability, expression and potential for drug-drug interactionsSemantic proximity Read ↗

Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.Semantic proximity Read ↗

Pharmacogenetic study of CES1 gene and enalapril efficacy.Semantic proximity Read ↗

Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.Semantic proximity Read ↗

Carboxylesterase 1A2 encoding gene with increased transcription and potential rapid drug metabolism in Asian populations.Semantic proximity Read ↗

Pharmacogenomic assessment of carboxylesterases 1 and 2.Semantic proximity Read ↗

The Impact of Carboxylesterases in Drug Metabolism and PharmacokineticsSemantic proximity Read ↗

Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.Semantic proximity Read ↗

Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.